10.3390/tropicalmed8030163 90 StefanoK.MarcoM.FedericaG.LauraB.BarbaraB.GioacchinoL.et al (2018)
Weight loss associated with vagus nerve stimulation
Murthy SK, Malhotra AK, Mani S, Maryam EA, Shara EE, Al-Rowaished M, Naveed S, Alkhayat AI, Alali MT (2007) Incidence of Down Syndrome in Dubai, UAE
The study evaluated multiple dose levels over a 48-week period and reported dose-dependent reductions in body weight alongside improvements in several cardiometabolic biomarkers
For alcohol specifically, naltrexone is the established, FDA-approved option with far more evidence